Visit https://www.peervoice.com/MPR860 to view the entire programme with slides. After completing “Lise Lotte Gluud, MD - Following the Evidence-Based Road: Improving Care for MASH Through Use of Clinical Care Pathways in Primary Care”, participants will be able to: Apply strategies to identify patients who warrant additional screening for metabolic dysfunction-associated steatohepatitis (MASH) based on clinical suspicion and imaging; Discuss serum biomarkers and non-invasive screening techniques for fibrosis; and Describe guideline-recommended strategies for the management of comorbidities in patients with MASH.